Skip to content

Validation of the reduced morningness-eveningness questionnaire (rMEQ: reduced morningness-eveningness questionnaire) in Japanese

Validation study for the development of a Japanese version of the reduced morningness-eveningness questionnaire (rMEQ)

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1030230180
Enrollment
2243
Registered
2023-06-25
Start date
2023-06-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circadian rhythm disorders insomnia

Interventions

In Study 2, the subjects spend 6 hours in a dark (less than 1 lx illumination) laboratory and saliva is collected once an hour.
D003623

Sponsors

Kitamura Shingo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Study 1: 1) Persons who are between 20 and 79 years old at the time of response. 2) Who are able to respond to the questionnaire via the Internet. Study 2 1) Males and females between 20 and 60 years of age at the time of consent

Exclusion criteria

Exclusion criteria: Study 1:. 1) Persons with pre-existing medical conditions (cardiovascular, liver, endocrine system, brain/neurological, psychiatric, etc.), taking therapeutic drugs, or having a history of such conditions that may affect the study results 2) Persons who are dependent on alcohol or who are found to be in the habit of excessive alcohol consumption 3) Those who have a habit of taking drugs or supplements that affect sleep. 4) Pregnant, lactating, or planning to become pregnant during the study period 5) Who are using an implantable medical device such as a pacemaker 6) Any other person deemed inappropriate by the principal investigator. Study 2: The following are not included in the study 1) Persons with pre-existing medical conditions (cardiovascular, liver, endocrine, brain/neurological, psychiatric, etc.), taking therapeutic drugs, or having a history of such conditions that may affect the results of the study 2) Those who have engaged in time-lagged travel or shift work at least 6 months prior to the experiment. 3) Persons who have been found to be dependent on alcohol or to have excessive drinking habits 4) Persons with excessive smoking habits 5) Those who have a habit of taking drugs or supplements that affect sleep 6) Those with abnormal color vision 7) Those who have a phobia of dark places 8) Other subjects deemed inappropriate by the principal investigator

Design outcomes

Primary

MeasureTime frame
Association between chronotypes determined by MEQ and rMEQ, respectively Association between DLMO and sleep rhythm phase and chronotypes determined by rMEQ

Secondary

MeasureTime frame
Questionnaires with significant contribution to chronotype determination Association of chronotype with sleep irregularities

Contacts

Public ContactEto Taisuke

National Center of Neurology and Psychiatry

eto@ncnp.go.jp+81-42-346-2071

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026